Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Asgn (ASGN) Asset Writedowns and Impairment (2016 - 2019)

Historic Asset Writedowns and Impairment for Asgn (ASGN) over the last 9 years, with Q4 2019 value amounting to $15.9 million.

  • Asgn's Asset Writedowns and Impairment rose 85714.29% to $15.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was $18.9 million, marking a year-over-year change of. This contributed to the annual value of $18.9 million for FY2019, which is N/A changed from last year.
  • Latest data reveals that Asgn reported Asset Writedowns and Impairment of $15.9 million as of Q4 2019, which was up 85714.29% from $1.3 million recorded in Q3 2019.
  • In the past 5 years, Asgn's Asset Writedowns and Impairment registered a high of $15.9 million during Q4 2019, and its lowest value of -$2.1 million during Q4 2018.
  • Over the past 5 years, Asgn's median Asset Writedowns and Impairment value was $2.4 million (recorded in 2016), while the average stood at $2.7 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first tumbled by 17281.55% in 2018, then surged by 85714.29% in 2019.
  • Over the past 5 years, Asgn's Asset Writedowns and Impairment (Quarter) stood at $3.0 million in 2015, then decreased by 29.55% to $2.1 million in 2016, then skyrocketed by 36.68% to $2.9 million in 2017, then crashed by 172.82% to -$2.1 million in 2018, then surged by 857.14% to $15.9 million in 2019.
  • Its Asset Writedowns and Impairment was $15.9 million in Q4 2019, compared to $1.3 million in Q3 2019 and $1.1 million in Q2 2019.